Shares of the following companies are showing unusual moves in Tuesday's trading session .
Among the winners, BioLineRx rose sharply after the biopharmaceutical company announced a worldwide exclusive agreement with Genoscience to develop an oral treatment for Hepatitis C.
To the downside, shares of InterDigital plunged as the wireless-patent technology company said it had ended a strategic review and determined it would not put itself up for sale.